Drug Chatter -- Tracking biopharma stock chatter

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

UserTweets
@SleekMoneycom 12
@pennyflipper 11
@biotech_sector 10
@FatDuck3 10
@dailymailtimes 7

Recent Tweets for BCRX

storminvestor @storminvestor
$5.16 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/r8W1UTUNUr
September 23rd 2017, 9:09pm
SPNewsAnalysis @SPNewsAnalysis
$5.16 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/gL4EPWkEBC
September 23rd 2017, 9:09pm
poulcyber @poulcyber
$BCRX FDA Nice
September 23rd 2017, 6:09pm
noritsunagirota @noritsunagirota
Emory University Has Trimmed Its Stake in Biocryst Pharmaceuticals $BCRX as Share Price Declined ...
September 23rd 2017, 1:09pm
midetimes @midetimes
Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX Director Sells $294,035.00 in Stock https://t.co/CMija67kWw
September 23rd 2017, 10:09am
dailymailtimes @dailymailtimes
Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX Director Sells $294,035.00 in Stock https://t.co/Wivm1y1JPY
September 23rd 2017, 10:09am
dailypoliticaln @dailypoliticaln
Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX Director Sells $294,035.00 in Stock https://t.co/er6je8xpUC
September 23rd 2017, 10:09am
WKRBNews @WKRBNews
Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX Director Sells $294,035.00 in Stock https://t.co/VggqkTulkT
September 23rd 2017, 10:09am
SleekMoneycom @SleekMoneycom
BioCryst Pharmaceuticals, Inc. $BCRX Earns Sector Perform Rating from Analysts at Royal Bank Of Canada https://t.co/LjyG2R0gpw
September 23rd 2017, 9:09am
SleekMoneycom @SleekMoneycom
BioCryst Pharmaceuticals, Inc. $BCRX Receives “Overweight” Rating from Piper Jaffray Companies https://t.co/gUe0aS073J
September 23rd 2017, 3:09am
devnullius @devnullius
RT @SleekMoneycom: BioCryst Pharmaceuticals, Inc. $BCRX Upgraded to Overweight at J P Morgan Chase & Co https://t.co/Te71G9FVlO
September 23rd 2017, 2:09am
SleekMoneycom @SleekMoneycom
BioCryst Pharmaceuticals, Inc. $BCRX Upgraded to Overweight at J P Morgan Chase & Co https://t.co/Te71G9FVlO
September 23rd 2017, 2:09am
sales_js @sales_js
FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers $BCRX $AMPH https://t.co/HzbxGde0z1 via @TheStreet
September 22nd 2017, 3:09pm
MScreener @MScreener
BioCryst Pharmaceuticals, Inc.: Heavy volume for BioCryst Pharmaceuticals, Inc. stock. $BCRX https://t.co/7QLcC4CPH7 https://t.co/znSPbKZNaL
September 22nd 2017, 11:09am
MScreener @MScreener
BioCryst Pharmaceuticals, Inc.: Heavy volume for BioCryst Pharmaceuticals, Inc. stock. $BCRX https://t.co/7QLcC4CPH7 https://t.co/PkXFA4rad8
September 22nd 2017, 10:09am
InsidrFinancial @InsidrFinancial
$BCRX Here's A Play In BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) That Markets Just Missed https://t.co/KRxkoqDTih
September 22nd 2017, 10:09am
JustTradingHoy @JustTradingHoy
$BCRX on board for a bounce. It's holding the secondary well (even after slipping below it briefly, it bounced quick). Target $5.68
September 22nd 2017, 10:09am
AllStar_Trading @AllStar_Trading
All out of $BCRX at 5.20
September 22nd 2017, 9:09am
JustTradingHoy @JustTradingHoy
$BCRX at secondary pps moment of truth
September 22nd 2017, 9:09am
JustTradingHoy @JustTradingHoy
$BCRX what is the market numbers for the recently approved formula? Also watching to see if it holds secondary price for a bounce.
September 22nd 2017, 9:09am
PlexusVentures @PlexusVentures
FDA OKs @BioCrystPharma's #Rapivab for #Pediatric Indication https://t.co/rdADX9dhaX @TheStreet #influenza #antiviral #biotech $BCRX $AMPH
September 22nd 2017, 9:09am
TheMarketsDaily @TheMarketsDaily
Fred E. Cohen Sells 54,250 Shares of BioCryst Pharmaceuticals, Inc. $BCRX Stock https://t.co/jXHcdr6atq
September 22nd 2017, 8:09am
dakotafinancial @dakotafinancial
BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by Federated Investors Inc. PA https://t.co/hDtNCwUkEc
September 22nd 2017, 5:09am
SleekMoneycom @SleekMoneycom
BioCryst Pharmaceuticals’ $BCRX Buy Rating Reaffirmed at HC Wainwright https://t.co/6m34J12Odq
September 22nd 2017, 4:09am
SleekMoneycom @SleekMoneycom
BioCryst Pharmaceuticals, Inc. $BCRX Price Target Raised to $9.00 at J P Morgan Chase & Co https://t.co/rZGocBfaAc
September 22nd 2017, 3:09am
MomoTrader007 @MomoTrader007
@RaTrade why don't you pull up mu feed history and also see the losses i've had... anyway $BCRX = $NVAX = POS
September 22nd 2017, 3:09am
GoodKarmaTrades @GoodKarmaTrades
RT @AjAwesomecalls: $BCRX Boy what a joke this Co is Everytime this stock gets any kind of News You know what I do SHORT IT SHORT IT SHORT…
September 21st 2017, 10:09pm
AjAwesomecalls @AjAwesomecalls
$BCRX Boy what a joke this Co is Everytime this stock gets any kind of News You know what I do SHORT IT SHORT IT SH… https://t.co/SDOBxNA0Ca
September 21st 2017, 9:09pm
1MinuteStock @1MinuteStock
Wondering about risks of $BCRX? The 63-day volatility is 34.92% https://t.co/PJkDMq8jaV
September 21st 2017, 7:09pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $BCRX is $-0.17 it's -3.23% of the current price https://t.co/Sh0O4djPfy
September 21st 2017, 7:09pm
AllianceCBRN @AllianceCBRN
RT @shaneblackmon: $BCRX BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
September 21st 2017, 6:09pm
MomoTrader007 @MomoTrader007
$BCRX closed my 10% gain - told you to go short premarket.... another bad management biotech
September 21st 2017, 4:09pm
AllStar_Trading @AllStar_Trading
Entered $WTI 2.79 SL 2.71 PT 2.94-3.10, also entered $BCRX at 5.32 SL 5.20 PT 5.50-5.80-6.00 #AllStarTradingTeam
September 21st 2017, 4:09pm
JustTradingHoy @JustTradingHoy
$BCRX final question do you guy think is a target for like of $GSK ? This tiny companies can't really go at it alone? Can they? Prob not.
September 21st 2017, 4:09pm
JustTradingHoy @JustTradingHoy
$BCRX question for the experts. I read that the upcoming flu season will be very harsh. What's benefit does BCRX have over flu vs others?
September 21st 2017, 3:09pm
storminvestor @storminvestor
BioCryst Pharmaceuticals, Inc. $BCRX Director Fred E. Cohen Sells 54,250 Shares https://t.co/2pxIiWPGqe
September 21st 2017, 3:09pm
SPNewsAnalysis @SPNewsAnalysis
BioCryst Pharmaceuticals, Inc. $BCRX Director Fred E. Cohen Sells 54,250 Shares https://t.co/xCeMNTuEg1
September 21st 2017, 3:09pm
ITRADEVOL @ITRADEVOL
Last Trading Hour Summary Statistics - Last 20 Days Biocryst Pharmaceuticals stock $BCRX https://t.co/AS8IRUl281
September 21st 2017, 3:09pm
KAFinvesting @KAFinvesting
$BCRX goes red after releasing FDA approval news. Interesting.
September 21st 2017, 3:09pm
KelvinEWalker1 @KelvinEWalker1
you are going the wrong way!!! $BCRX
September 21st 2017, 2:09pm
bullz444 @bullz444
$BCRX what's happening here???
September 21st 2017, 2:09pm
JDoggs_Money @JDoggs_Money
$BCRX big volume today, but not much price action. Let's see how green we can close...
September 21st 2017, 1:09pm
ITRADEVOL @ITRADEVOL
$BCRX Option Order Flow Sentiment https://t.co/gaFIR12U9W
September 21st 2017, 1:09pm
FinInvTr @FinInvTr
Can $BCRX Turn Itself Around With This FDA Approval? https://t.co/d7XBUt2aUA
September 21st 2017, 1:09pm
scientwest @scientwest
$BCRX FBO Pre-solicitation Conference Event: Antiviral Pharmaceutical Purchase, Storage, and Distribution Solicitation Number: 2017-N-67352
September 21st 2017, 12:09pm
JohnGernannt @JohnGernannt
$BCRX 5.49+0.22 (+4.11%) on 5.4 mil traded more than 4 X ave vol
September 21st 2017, 12:09pm
Gew991977 @Gew991977
$BCRX Drops earnings mid day. Didn’t see anything good in the earnings report. Just nervous shorts reacting. Maybe I’m wrong though
September 21st 2017, 12:09pm
KAFinvesting @KAFinvesting
Alerted the dip buy on $BCRX in 5.20's just hit 5.50's :D congrats members!!! ???
September 21st 2017, 12:09pm
anajjar1997 @anajjar1997
$BCRX when will it jump? Any ideas?
September 21st 2017, 12:09pm
mr_bukz @mr_bukz
$BCRX buy at 5.41. SL 5.36
September 21st 2017, 11:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.